HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathon R Campbell Selected Research

9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)

1/2022Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
1/2021Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
1/2021The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
1/2021Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathon R Campbell Research Topics

Disease

22Tuberculosis (Tuberculoses)
04/2022 - 01/2017
6Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022 - 01/2019
6Latent Tuberculosis
01/2021 - 09/2017
2Infections
11/2021 - 01/2020
2HIV Infections (HIV Infection)
01/2021 - 01/2020
2COVID-19
01/2020 - 01/2020
1Hepatitis
11/2021
1Diabetes Mellitus
11/2021
1Renal Insufficiency (Renal Failure)
11/2021
1Extensively Drug-Resistant Tuberculosis
01/2021
1Exanthema (Rash)
01/2020
1Silicosis
11/2019
1Blister (Bulla)
01/2019
1Pulmonary Tuberculosis
01/2017

Drug/Important Bio-Agent (IBA)

12Rifampin (Rifampicin)FDA LinkGeneric
04/2022 - 01/2017
8Pharmaceutical PreparationsIBA
11/2021 - 09/2017
6Isoniazid (Ftivazide)FDA LinkGeneric
01/2022 - 01/2019
49 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022 - 01/2021
3bedaquiline (R207910)IBA
04/2022 - 01/2021
3Tuberculin (PPD)IBA
11/2021 - 01/2019
3Interferon-gamma (Interferon, gamma)IBA
11/2021 - 01/2017
2AcidsIBA
01/2022 - 01/2020
2Linezolid (Zyvox)FDA Link
01/2022 - 01/2021
1terizidoneIBA
01/2022
1Cycloserine (Seromycin)FDA Link
01/2022
1OPC-67683IBA
01/2022
1Nucleic AcidsIBA
01/2022
1Aminosalicylic Acid (Rezipas)FDA Link
01/2022
1Carbapenems (Carbapenem Antibiotics)IBA
01/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2021
1FluoroquinolonesIBA
01/2021
1AntigensIBA
10/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1Antitubercular AgentsIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019

Therapy/Procedure

9Therapeutics
01/2021 - 01/2017
3Injections
01/2022 - 01/2019
1Aftercare (After-Treatment)
01/2022
1Contraindications
01/2020
1Art Therapy
01/2020
1Home Nursing (Nursing, Home)
01/2020
1Drug Therapy (Chemotherapy)
09/2017